| Product Name | MF | CAS | Details |
|---|
| GABRB3 Blocking Peptide | Details |
| Erastin | C30H31ClN4O4 | 571203-78-6 | Details |
| Methyl 4-caffeoylquinate | C17H20O9 | 123372-74-7 | Details |
| 2-Phenylmethanesulfonyl-1H-1,3-benzodiazole | C14H12N2O2S | 100872-42-2 | Details |
| 4-(2-Oxo-1,3-diazinan-1-yl)benzonitrile | C11H11N3O | 163918-99-8 | Details |
| 1-(2-Amino-5-methylthiazol-4-yl)ethanone | C6H8N2OS | 40353-62-6 | Details |
| Reutericyclin | C20H31NO4 | 303957-69-9 | Details |
| Exostemin | C18H16O6 | 16281-62-2 | Details |
| 2-tert-Butyl-5-chloroaniline | C10H14ClN | 25414-78-2 | Details |
| Methyl 1-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate | C13H20BNO4 | 1351379-23-1 | Details |
| 2-Amino-3-(4-chloro-1-methyl-1H-pyrazol-3-yl)propanoic acid hydrochloride | C7H11Cl2N3O2 | 1432026-01-1 | Details |
| Cythioate | C8H12NO5PS2 | 115-93-5 | Details |
| 2-Ethyl-N-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-7-amine | C10H16N2S | 1247417-17-9 | Details |
| MINK1 antibody | Details |
| GSK 3186899 | C19H28F3N7O3S | 1972617-87-0 | Details |
| 4'-Chloro-3'-methylacetophenone, 95% | C9H9ClO | 37074-39-8 | Details |
| quinoline-2,6-diamine | C9H9N3 | 855837-85-3 | Details |
| Gossypin | C21H20O13 | 652-78-8 | Details |
| 5-(2-Methoxyethoxy)pyrazine-2-carbonitrile | C8H9N3O2 | 1339691-29-0 | Details |
| HIPK4 antibody | Details |
| 5-[(4-Ethoxyphenoxy)methyl]-2-furohydrazide | C14H16N2O4 | 438464-88-1 | Details |
| (Des-Gly10,tBu-D-Gly6,Pro-NHEt 9)-LHRH trifluoroacetate | C59H84N16O12 | 61012-19-9 | Details |
| (4-Fluorotetrahydro-2H-pyran-4-yl)methanol | C6H11FO2 | 883442-46-4 | Details |
| 2-Chloro-5-nitroaniline | C6H5ClN2O2 | 6283-25-6 | Details |
| 5-Fluororesorcinol | C6H5FO2 | 75996-29-1 | Details |
| Mal(11.1) | C24H46O11 | 1219008-49-7 | Details |
| HNRPUL1 antibody | Details |
| SLC39A7 antibody | Details |
| PDGFR Tyrosine Kinase Inhibitor IV | C18H16FN3O2 | 627518-40-5 | Details |
| 1,3,4,6-Tetra-O-acetyl-2-deoxy-D-glucopyranose | C14H20O9 | 69515-91-9 | Details |
| N(4)-(N-(6-Trifluoroacetylamidocaproyl)-2-aminoethyl)-5'-O-DMT-5-methyl-2'-deoxycytidine-3'-N,N-diisopropylmethylphosphoramidite | C48H64F3N6O10P | 117032-52-7 | Details |
| 5-Oxomefruside | C13H17ClN2O6S2 | 14599-36-1 | Details |
| Tetanus Toxoid Antigen | Details |
| 2,3-Dihydroxy-1-piperidinecarboxylic acid phenylmethyl ester | C13H17NO4 | 473436-50-9 | Details |
| 3-Methyl-5-phenyl-1H-pyrazol-4-amine | C10H11N3 | 112884-51-2 | Details |
| Budralazine | C14H16N4 | 36798-79-5 | Details |
| CD105 antibody (biotin) | Details |
| Fexofenadine Impurity G | C32H37NO3 | 1187954-57-9 | Details |
| iota-Carrageenan | C24H34O31S4-4 | 9062-07-1 | Details |
| 9Alpha,11,12-Trihydroxydrim-7-en-6-one | C15H24O4 | 192566-65-7 | Details |
| Methyl 2-(3,4-dichlorophenyl)-2-(methylamino)acetate hydrochloride | C10H12Cl3NO2 | 1251922-87-8 | Details |
| H-ILAR-OH | Details |
| (4-tert-Butylpyridin-2-yl)methanamine | C10H16N2 | 608515-12-4 | Details |
| Methyl (2E)-3-(6-chloropyridin-3-yl)prop-2-enoate | C9H8ClNO2 | 188524-63-2 | Details |
| (Dimethyl-4H-1,2,4-triazol-3-yl)(phenyl)methanamine | C11H14N4 | 1250018-03-1 | Details |
| 3,4,5-Trimethoxyphenylacetic acid | C11H14O5 | 951-82-6 | Details |
| 2-[4-(Hydroxymethyl)phenoxy]acetonitrile | C9H9NO2 | 123226-38-0 | Details |
| 1-[3,5-Dimethyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]ethan-1-amine | C9H14F3N3 | 1343793-69-0 | Details |
| 2,2-Diethoxyacetophenone | C12H16O3 | 6175-45-7 | Details |
| 3-Hydroxy-1H-isoindole-1-carboxylic acid | C9H7NO3 | 20361-09-5 | Details |
| 3-Hydroxy-N-(2-methoxy-5-methylphenyl)naphthalene-2-carboxamide | C19H17NO3 | 54079-43-5 | Details |
| eCF506 | C26H38N8O3 | 1914078-41-3 | Details |
| eFT 508 | C17H20N6O2 | 1849590-01-7 | Details |
| 4-[2-(Dimethylamino)ethyl]piperidin-4-ol | C9H20N2O | 1781791-65-8 | Details |
| Picroside 2 | C23H28O13 | 39012-20-9 | Details |
| Methyl 2-amino-3-hydroxybutanoate hydrochloride | 2170123-34-7 | Details |
| 1,5-Diamino-4,8-dihydroxyanthraquinone, contain 1,8-Diamino-4,5-dihydroxyanthraquinone | C14H10N2O4 | 145-49-3 | Details |
| 6-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | C9H5F3N2O2 | 1018828-69-7 | Details |
| ABP 688 | C15H16N2O | 924298-51-1 | Details |
| TSN antibody | Details |
| Enavatuzumab | 1062149-33-0 | Details |
| 4-(1H-Indol-3-yl)-4-methylpentan-2-one | C14H17NO | 21973-02-4 | Details |
| 1-Phenyl-5-(propan-2-yl)-1H-pyrazol-4-amine hydrochloride | C12H16ClN3 | 1795506-87-4 | Details |
| 5-Chloro-1H-1,8-naphthyridin-2-one | C8H5ClN2O | 250264-28-9 | Details |
| 4-(3-Methyl-1,2,4-oxadiazol-5-yl)butanoic acid | C7H10N2O3 | 1038356-82-9 | Details |
| 5-Chloro-3-(4-chlorophenyl)-1H-1,2,4-triazole | C8H5Cl2N3 | 1315370-96-7 | Details |
| 5,5-dimethyl-3-(4-methylpiperazinyl)cyclohex-2-en-1-one | C13H22N2O | 81820-75-9 | Details |
| 3-methyl-3-azabicyclo[3.2.1]octan-8-one | C8H13NO | 4146-34-3 | Details |
| 3-(1-Amino-2-methylbutyl)benzoic acid hydrochloride | C12H17NO2.ClH | 2361743-90-8 | Details |
| CD150 antibody (FITC) | Details |
| Ethyl 7-bromo-2-chloroquinoline-4-carboxylate | C12H9BrClNO2 | 762260-65-1 | Details |
| 4-(Benzyloxy)-3-chloro-5-methoxybenzaldehyde | C15H13ClO3 | 37687-67-5 | Details |
| 1,4-bis(5-(trifluoromethyl)-2-pyridyl)piperazine | C16H14F6N4 | 131136-84-0 | Details |
| 3-Ethoxy-7-oxaspiro[3.5]nonan-1-ol | C10H18O3 | 1803582-80-0 | Details |
| Perilipin antibody | Details |
| Methyl 3-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | C8H6BrNO2S | 1105187-36-7 | Details |
| 2-(4-Methoxynaphthalen-1-yl)ethan-1-amine hydrochloride | 1049698-13-6 | Details |
| 5-Amino-N-(2-chlorophenyl)-2-methoxybenzene-1-sulfonamide | C13H13ClN2O3S | 726150-67-0 | Details |
| [4-(Thien-2-yl)phenyl]methanol | C11H10OS | 81443-44-9 | Details |
| 1-[3-(Propan-2-yl)phenyl]-5-propyl-1H-1,2,3-triazole-4-carboxylic acid | C15H19N3O2 | 1097050-94-6 | Details |
| SUMF1 protein (His tag) | Details |
| 3,4-Dimethyl-5-nitrobenzene-1-sulfonamide | C8H10N2O4S | 838838-15-6 | Details |
| 3',4'-Dihydroxyflavanone | C15H12O4 | Details |
| N-Omega-allyl-L-arginine | C9H18N4O2 | 139461-37-3 | Details |
| Pd-173074-d9 | C28H41N7O3 | 1794979-29-5 | Details |
| SARS-CoV-2 Nucleocapsid Antigen (SA Variant – B.1.351), Recombinant | Details |
| Phenyl 2,3,4-tri-O-acetyl-a-L-thiorhamnopyranoside | C18H22O7S | 108740-74-5 | Details |
| Naltrexone 3-D-glucuronide-D4 | Details |
| 2-[4-(Trifluoromethyl)phenyl]cyclohexan-1-amine | C13H16F3N | 1375473-81-6 | Details |
| 8-Amino-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-ol | C11H15NO2 | 2126161-11-1 | Details |
| 2-{[(2,4-Dichlorophenyl)methyl]sulfanyl}acetic acid | C9H8Cl2O2S | 65051-31-2 | Details |
| 1-[(4-Bromophenyl)methyl]-5-methyl-1H-pyrazol-3-amine | C11H12BrN3 | 956440-83-8 | Details |
| 2,5-Dihydrothiophene-3-sulfonyl chloride 1,1-dioxide | C4H5ClO4S2 | 112161-61-2 | Details |
| 2-(3-tert-Butylphenoxy)acetic acid | C12H16O3 | 1878-55-3 | Details |
| 3-Fluoro-4-(morpholin-4-yl)benzonitrile | C11H11FN2O | 588708-64-9 | Details |
| Recombinant Mouse CCL6 | Details |
| 4-(Carbamoylmethoxy)-3-chloro-5-methoxybenzoic acid | C10H10ClNO5 | 923224-95-7 | Details |
| tert-Butyl 4-cyano-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | C13H13N3O2 | 1803586-12-0 | Details |
| Guf1 Blocking Peptide | Details |
| Clavesin antibody | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||